Instead patients with low intra-tissue concentration of estrone coupled with low estrogen receptor ESR1 expression showed increased CRC recurrence compared to patients with high ESR1 mRNA levels and high E1 concentration. This evidence concerns the gene ESR1 and colorectal carcinoma.